Brief: Woodford Investment Management reports 26.2% stake in Northwest Biotherapeutics as of June 9, 2015
16/09/2015 19:10
Sept 16 (Reuters) - Northwest Biotherapeutics Inc NWBO.O : * Woodford Investment Management LLP reports 26.2% stake in Northwest Biotherapeutics Inc as of June 9, 2015 - SEC filing * Woodford Investment Management LLP says acquired securities of Northwest Biotherapeutics were undervalued * Source text: http://1.usa.gov/1UVjOyb * Further company coverage NWBO.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Northwest Biotherapeutics
See all newsBrief: Northwest Biotherapeutics And The UK National Health Service Blood And Transplant Announce Collaboration To Support Dcvax®-L Production
Brief: Northwest Biotherapeutics Provides Update On Final Preparations For Marketing Authorization Application
Brief: Northwest Biotherapeutics Provides Update On Near Term Plans For Submission Of Marketing Authorization Application
Brief: Northwest Biotherapeutics And Advent Bioservices Announce Receipt Of License For Commercial Manufacturing At Sawston, U.K. Facility
Brief: Northwest Biotherapeutics Announces That It Has No Banking Relationship With SVB